Article Information
PubMed
Published By
History
- Received January 27, 2012
- Revision received October 16, 2012
- Accepted October 18, 2012
- First published January 9, 2013.
- Version of record published January 9, 2013.
Copyright & Usage
Copyright © 2013 the authors 0270-6474/13/330397-14$15.00/0
Author Information
- Chhavy Tep1,3,
- Tae Hee Lim1,
- Pyung On Ko1,
- Sami Getahun1,
- Jae Cheon Ryu1,
- Virginia M. Goettl1,
- Stephen M. Massa4,
- Michele Basso2,
- Frank M. Longo5, and
- Sung Ok Yoon1
- 1Departments of Molecular and Cellular Biochemistry, and
- 2Physical Therapy, and
- 3Biochemistry Program, The Ohio State University, Columbus, Ohio 43210,
- 4Department of Neurology, University of California at San Francisco, San Francisco, California 94121, and
- 5Department of Neurology and Neurological Science, Stanford University, Stanford, California 94305
Author contributions
Author contributions: C.T. and S.O.Y. designed research; C.T., T.H.L., P.O.K., S.G., J.C.R., and V.M.G. performed research; S.M.M. and M.B. contributed unpublished reagents/analytic tools; C.T., F.M.L., and S.O.Y. analyzed data; C.T., F.M.L., and S.O.Y. wrote the paper.
Disclosures
- Received January 27, 2012.
- Revision received October 16, 2012.
- Accepted October 18, 2012.
This work was funded by grants from the National Institute of Neurological Disorders and Stroke (NINDS) (RO1NS050585, R21NS059503) and the Christopher and Dana Reeve Foundation to S.O.Y., and The Ohio State Neuroscience Center Core from NINDS (P30NS045758). We thank Drs. Barbara Hempstead, Bruce Carter, and Elizabeth Coulson for providing p75 knock-out mice.
F.M.L. is a founder of PharmatrophiX, a company focused on the development of neurotrophin receptor ligands.
- Correspondence should be addressed to Dr. Sung Ok Yoon, Department of Molecular and Cellular Biochemistry, 184 Rightmire Hall, Ohio State University, 1060 Carmack Road, Columbus, OH 43210. Sung.yoon{at}osumc.edu
Online Impact
Article usage
In this issue
Oral Administration of a Small Molecule Targeted to Block proNGF Binding to p75 Promotes Myelin Sparing and Functional Recovery after Spinal Cord Injury
